Cell-intrinsic PD-L1 ablation sustains effector CD8+ T cell responses and promotes antitumor T cell therapy
Cell Reports · 2024-02 · 43 (2) · 113712
DOI: 10.1016/j.celrep.2024.113712 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024-02. Verfasst von Xinran Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Shanghai Key Laboratory of Gynecologic Oncology, State Key Laboratory of Oncogenes and Related Genes, Renji …. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China Stem Cell and Translational Research, Thousand Young Talents Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Shanghai Key Laboratory of Gynecologic Oncology, State Key Laboratory of Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai…
- Shanghai Frontiers Science Center of Drug Target Identification and Delivery, National Key Laboratory of Innovative Immunotherapy, School of Pharmaceutical Science, Shanghai Jiao Tong University, Shanghai 200240, China.
- Shanghai Frontiers Science Center of Drug Target Identification and Delivery, National Key Laboratory of Innovative Immunotherapy, School of Pharmaceutical Science, Shanghai Jiao Tong University, Shanghai 200240, China;…
- Shanghai Institute of Immunology, Department of Immunology and Microbiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shang…
- Shanghai Frontiers Science Center of Drug Target Identification and Delivery, National Key Laboratory of Innovative Immunotherapy, School of Pharmaceutical Science, Shanghai Jiao Tong University, Shanghai 200240, China.…
Förderung
- National Key Research and Development Program of China Stem Cell and Translational Research
- Thousand Young Talents Program of China
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- National Key Research and Development Program of China
- Shanghai Jiao Tong University
Zitieren
APA
Wang, X., Lu, L., Hong, X., Wu, L., Yang, C., Wang, Y., Li, W., Yang, Y., Cao, D., Di, W., & Deng, L. (2024). Cell-intrinsic PD-L1 ablation sustains effector CD8+ T cell responses and promotes antitumor T cell therapy. Cell Reports, 43(2), 113712. https://doi.org/10.1016/j.celrep.2024.113712
Vancouver
Wang X, Lu L, Hong X, Wu L, Yang C, Wang Y, et al. Cell-intrinsic PD-L1 ablation sustains effector CD8+ T cell responses and promotes antitumor T cell therapy. Cell Reports. 2024;43(2):113712. doi:10.1016/j.celrep.2024.113712
BibTeX
@article{Wang2024,
author = {Wang, Xinran and Lu, Lu and Hong, Xiaochuan and Wu, Lingling and Yang, Chao and Wang, You and Li, Wenwen and Yang, Yuanqin and Cao, Dongqing and Di, Wen and Deng, Liufu},
title = {Cell-intrinsic PD-L1 ablation sustains effector CD8+ T cell responses and promotes antitumor T cell therapy},
journal = {Cell Reports},
year = {2024},
volume = {43},
number = {2},
pages = {113712},
doi = {10.1016/j.celrep.2024.113712}
}
EUVIMED